TFA
ROIV icon

Transamerica Financial Advisors’s Roivant Sciences ROIV Stock Holding History

Transamerica Financial Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.71K Buy
105
+45
+75% +$1.33K ﹤0.01% 1194
2026
Q1 		$1.66K Buy
60
+55
+1,100% +$1.41K ﹤0.01% 1248
2025
Q4 		$109 Hold
5
– – ﹤0.01% 1648
2025
Q3 		$76 Buy
+5
New +$62 ﹤0.01% 1542

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Transamerica Financial Advisors's ROIV Position: Q2 2026 in Review

Transamerica Financial Advisors increased its Roivant Sciences (ROIV) stake by 75% in Q2 2026, buying an estimated $1.33K and bringing the position to 105 shares worth $3.71K. The position accounts for ﹤0.01% of the portfolio, ranked #1194.

Transamerica Financial Advisors first reported a position in ROIV in Q3 2025 and has held it in 4 quarters since. 497 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Transamerica Financial Advisors held 105 shares of Roivant Sciences worth $3.71K as of Q2 2026.
  • Transamerica Financial Advisors bought 45 Roivant Sciences shares in Q2 2026, an estimated $1.33K.
  • Roivant Sciences made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #1194 holding.
  • Transamerica Financial Advisors first reported a position in Roivant Sciences in Q3 2025 and has held it in 4 quarters since.
  • 497 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.